Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01951599 · ClinicalTrials.gov registry record · Phase 1
To Determine the Relative Bioavailability of Different Formulations of AZD9291 and the Effect of Food.
A Phase 1 study, sponsored by AstraZeneca.
- Completed
- Registry status
- Phase 1
- Development phase
- 35
- Enrollment target
NCT01951599 is a Phase 1 study that has completed, run by AstraZeneca. The registered enrollment target is 35 participants.
The verdict
NCT01951599, a Phase 1 study, has completed, sponsored by AstraZeneca.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 35 participants
- Enrollment target
Study Summary
To determine the relative bioavailability of different oral formulations of AZD9291 and the effect of food in healthy volunteers.
Interventions
- DRUG AZD9291
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2013-10-09 |
| Est. Completion | 2014-06-04 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01951599
The ClinicalTrials.gov registry entry for NCT01951599 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is AstraZeneca, which has 1,285 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which AZD9291 is the first listed.
NCT01951599 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01951599 about?
NCT01951599 is a clinical study titled "To Determine the Relative Bioavailability of Different Formulations of AZD9291 and the Effect of Food.". To determine the relative bioavailability of different oral formulations of AZD9291 and the effect of food in healthy volunteers.
What is the current status of trial NCT01951599?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 35 participants. The study started on 2013-10-09. Estimated completion is 2014-06-04.
What interventions are being tested in trial NCT01951599?
The interventions under investigation include: AZD9291 (DRUG).
Who is sponsoring clinical trial NCT01951599?
This trial is sponsored by AstraZeneca, which has 1,285 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.